PATENT CLAIM ANALYSIS

Application Number: 16101861
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "158100"]

Abstract:
Antibodies that bind the apple 2 domain of human coagulation Factor XI and inhibit activation of FXI by coagulation factor XIIa are described.

Claim (Index 2):
The antibody or antigen binding fragment of  claim 1 , wherein the antibody or antigen binding fragment comprises:\n (i) the HC CDRs having the amino acid sequences set forth in SEQ ID NO:1, SEQ ID NO:2, and SEQ ID NO:3 for HC CDR1, CDR2, and CDR3 and the LC CDRs having the amino acid sequences set forth in SEQ ID NO:4, SEQ ID NO:5, and SEQ ID NO:6 for LC CDR1, CDR2, and CDR3; or (ii) the HC CDRs having the amino acid sequences set forth in SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:9 for HC CDR1, CDR2, and CDR3 and the LC CDRs having the amino acid sequences set forth in SEQ ID NO:10, SEQ ID NO:11, and SEQ ID NO:12 for LC CDR1, CDR2, and CDR3.

Metadata:
- Claim Count in Document: 122.0
- Percentile: 96.0
- Lexical Diversity: 1.09091
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15409607', '15619620', '16335133', '15906773', '15934526']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7806212308727537
- 35 USC 102 Novelty (BERT): 0.7162729203525496
- Combined Prediction Score: 0.7741863998207333
- Mean Citation Score: 558.16293
- Max Citation Score: 887.4425699999997
- Similarity Product: 735.8838027777348

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test